Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 Research — Stemcode Peptides

Published studies, mechanisms, and third-party reports for CJC-1295 (GHRH Analogue). For laboratory research use only.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

CJC-1295

GHRH Analogue

CJC-1295 is a synthetic 30-amino acid peptide analogue of growth hormone-releasing hormone (GHRH). Modified for enhanced stability, it activates pituitary GHRH receptors to stimulate pulsatile growth hormone release.

GHRH Receptor Agonism

Pulsatile GH Release

Extended Half-Life

Pituitary Activation

Quantified findings reported in the literature

amino acid residues in the CJC-1295 peptide sequence

Teichman et al., J Clin Endocrinol Metab 2006 ↗

verified purity by HPLC analysis in every Stemcode batch

Stemcode Peptides COA data

Published, peer-reviewed studies

Prolonged stimulation of growth hormone secretion by CJC-1295

Clinical study demonstrating CJC-1295's ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 levels.

Growth hormone-releasing hormone analogues: chemistry and pharmacology

Third-party analytical reports

Certificates of Analysis from independent laboratories for products supplied by Stemcode. Reported values describe the analysed material; they are reported as documented and are distinct from the published literature above.

Stemcode supplies CJC-1295 as a research-grade compound for laboratory research use only — not for human or animal consumption.

Connected topics

Follow this recovery question